NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/13/2026
Back to search
Official data from USPTO
DRUGZEVY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DRUGZEVY
ST13
US500000099020963Class
42, 44
Filing
99020963
Registration
8099101
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
01/13/2026
Trademark type
Word
Nice classes
42, 44
Filing date
01/28/2025
Registration date
01/13/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/13/2026
Last transaction
01/13/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
11/21/2024
First use in commerce
11/21/2024
Drawing code
4
Owner type
03
Owner location
New York, NY, US
Examiner
WOOD, CAROLINE
Law office
M10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Click Therapeutics, Inc.
Representatives
Katherine P. Califa Foley & Lardner LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing medical and scientific research information in the field of digital therapeutics servicesneuromodulation therapy servicessoftware as a medical device (samd)clinical trialsbehavioral health servicescustom design of computer softwaredesign and development of computer softwarehealth care services for treating human health conditionsbehaviorsdiseases using digital therapeutics; Providing technology and software development information in the fields of software as a medical device (samd)clinical trialscustom design of computer software and design and development of computer software; Providing medical and scientific research information in the field of clinical trials
Class 44
Providing medical information to patientsmedical professionals and pharmaceuticalmedical and health care companies in the form of reportswhite paperspredictive analyticsvisualization and research results and studies in the field of digital therapeutics servicesneuromodulation therapy servicesbehavior health services; Provision of health information in the field of health care services for neuromodulation therapy and treating human health conditionsbehaviors and using digital therapeutics; Provision of medical information relating to neuromodulation therapy and treating human health conditionsbehaviors and using digital therapeutics; Medical information provided via the internet; Providing healthcare information via the internet; Providing medical information in the fields of neuromodulation therapy and digital therapeutics via the Internet
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/13/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/25/2025
PUBO
PUBLISHED FOR OPPOSITION
11/25/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/19/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/30/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/07/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
06/16/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
06/16/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/10/2025
GNRT
NON-FINAL ACTION E-MAILED
04/10/2025
CNRT
NON-FINAL ACTION WRITTEN
04/10/2025
DOCK
ASSIGNED TO EXAMINER
04/03/2025
MAFR
APPLICATION FILING RECEIPT MAILED
01/28/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/28/2025
NWAP
NEW APPLICATION ENTERED
01/28/2025
Continuous trademark protection
Get notified about every new filing that threatens DRUGZEVY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.